Efficacy and safety of newer P2Y(12) inhibitors for acute coronary syndrome: a network meta-analysis

Whether newer P2Y(12) inhibitors are more efficacious and safer than clopidogrel and whether there is a superior one remain uncertain. We compared the effect of P2Y(12) inhibitors on clinical outcomes in patients with acute coronary syndrome (ACS). Randomized controlled trials comparing clopidogrel,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Yue, Lam, Cheuk Kiu, Cheung, Bernard Man Yung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545197/
https://www.ncbi.nlm.nih.gov/pubmed/33033323
http://dx.doi.org/10.1038/s41598-020-73871-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545197/
https://www.ncbi.nlm.nih.gov/pubmed/33033323
http://dx.doi.org/10.1038/s41598-020-73871-x

Ejemplares similares